Shkreli's Pharma Venture Loses Bid To Limit Profit Payback

By Christopher Cole · September 27, 2021, 6:14 PM EDT

Incarcerated former pharmaceutical executive Martin Shkreli and Vyera Pharmaceuticals cannot put geographic limits on the profits they may have to cough up after spiking the price of a lifesaving drug, a...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Federal Trade Commission et al v. Vyera Pharmaceuticals, LLC et al

Case Number

Court

New York Southern

Nature of Suit

Banks and Banking

Date Filed

January 27, 2020

Recent Articles By Christopher

November 28, 2023
FCC To Ease Signing-Up For Rural Health Funding Projects
November 28, 2023
Advocates Worry 988 Hotline Georouting Will Get Delayed
September 12, 2023
Lead-Covered Verizon Cables Put Workers At Risk, Suit Says
July 20, 2023
FCC Requires Providers To Report 988 Crisis Line Outages
April 24, 2023
Shentel Fined $227K For 911 Audio Outages
January 26, 2023
FCC Aims To Improve Outage Reporting For 988 Hotline
January 26, 2023
FCC Reworks Payment Model For Rural Health Connectivity
January 20, 2023
FCC Urged To Keep Telehealth Rates' Status Quo For Now
July 27, 2022
House Votes To Extend FCC's Spectrum Auction Powers
April 05, 2022
Windstream To Pay $1.2M In FCC Settlement Over Rural Rates